Garro et al., 2013 - Google Patents
Penetratin and derivatives acting as antibacterial agentsGarro et al., 2013
View PDF- Document ID
- 9141261413033733757
- Author
- Garro A
- Olivella M
- Bombasaro J
- Lima B
- Tapia A
- Feresin G
- Perczel A
- Somlai C
- Penke B
- López Cascales J
- Rodríguez A
- Enriz R
- Publication year
- Publication venue
- Chemical Biology & Drug Design
External Links
Snippet
The synthesis, in vitro evaluation and conformational study of penetratin and structurally related derivatives acting as antibacterial agents are reported. Among the compounds evaluated here, two methionine sulphoxide derivatives (RQIKIWFQNRRM [O] KWKK‐NH 2 …
- 108010043655 penetratin 0 title abstract description 44
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/10—Peptides having 12 to 20 amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
- A61K47/30—Macromolecular compounds
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin, zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Jia et al. | The effect of halogenation on the antimicrobial activity, antibiofilm activity, cytotoxicity and proteolytic stability of the antimicrobial peptide Jelleine-I | |
Saravanan et al. | Structure, activity and interactions of the cysteine deleted analog of tachyplesin-1 with lipopolysaccharide micelle: Mechanistic insights into outer-membrane permeabilization and endotoxin neutralization | |
Sakagami et al. | Importance of net hydrophobicity in the cellular uptake of all-hydrocarbon stapled peptides | |
Deshayes et al. | Insight into the mechanism of internalization of the cell-penetrating carrier peptide Pep-1 through conformational analysis | |
Zhao et al. | Probing ion channel activity of human islet amyloid polypeptide (amylin) | |
Glossop et al. | Battacin-inspired ultrashort peptides: nanostructure analysis and antimicrobial activity | |
Khemtemourian et al. | Residue specific effects of human islet polypeptide amyloid on self-assembly and on cell toxicity | |
Attoub et al. | Anti-tumor activities of the host-defense peptide hymenochirin-1B | |
Garro et al. | Penetratin and derivatives acting as antibacterial agents | |
Bodapati et al. | Design, synthesis and evaluation of antimicrobial activity of N-terminal modified Leucocin A analogues | |
Kanchi et al. | Polyproline chains destabilize the Alzheimer’s amyloid-β protofibrils: A molecular dynamics simulation study | |
Ghosh et al. | NMR structure and binding of esculentin-1a (1–21) NH2 and its diastereomer to lipopolysaccharide: correlation with biological functions | |
Levine et al. | The mitochondrial peptide humanin targets but does not denature amyloid oligomers in type II diabetes | |
Luo et al. | Human defensin-inspired discovery of peptidomimetic antibiotics | |
Shulepko et al. | Towards universal approach for bacterial production of three-finger Ly6/uPAR proteins: Case study of cytotoxin I from cobra N. oxiana | |
Maurya et al. | Mitochondrial VDAC2 and cell homeostasis: highlighting hidden structural features and unique functionalities | |
Juretić et al. | Designed peptide with a flexible central motif from ranatuerins adapts its conformation to bacterial membranes | |
Chen et al. | Inhibiting human calcitonin fibril formation with its most relevant aggregation-resistant analog | |
Fei et al. | A frog‐derived antimicrobial peptide as a potential anti‐biofilm agent in combating Staphylococcus aureus skin infection | |
Herrera‐León et al. | The impact of phosphatidylserine exposure on cancer cell membranes on the activity of the anticancer peptide HB43 | |
Hsu et al. | Optimization of sequence and chiral content enhances therapeutic potential of tilapia piscidin peptides | |
Kulon et al. | The His–His sequence of the antimicrobial peptide demegen P-113 makes it very attractive ligand for Cu2+ | |
Parravicini et al. | Small peptides derived from penetratin as antibacterial agents | |
US20120197004A1 (en) | Novel anti-microbial peptidomimetic compounds and methods to calculate anti-microbial activity | |
Cardon et al. | Peptidoglycan potentiates the membrane disrupting effect of the carboxyamidated form of DMS-DA6, a Gram-positive selective antimicrobial peptide isolated from Pachymedusa dacnicolor skin |